Serological diagnosis and post-treatment monitoring of Echinococcus granulosus in experimentally infected dogs using crude and recombinant fibronectin antigens

dc.contributor.authorFigen Celik
dc.contributor.authorMuhammed Ahmed Selcuk
dc.contributor.authorMuhammet Uslug
dc.contributor.authorSami Simsek
dc.date.accessioned2025-06-10T12:00:50Z
dc.date.available2025-06-10T12:00:50Z
dc.date.issued2025-07
dc.departmentFakülteler, Veteriner Fakültesi, Klinik Öncesi Bilimleri Bölümü
dc.description.abstractEchinococcus granulosus is a zoonotic helminth responsible for cystic echinococcosis, a significant public health concern. The diagnosis of E. granulosus infections in definitive hosts, such as dogs, is challenging due to the absence of clinical signs. This study aimed to evaluate the diagnostic performance of crude (EgSCA) and recombinant (rEgFN162) antigens for the detection of E. granulosus infection in dogs using ELISA and Western blot assays. Additionally, it sought to identify the most suitable antigen and method for population-based screening and post-treatment monitoring. Adult E. granulosus parasites were collected from experimentally infected dogs using arecoline hydrobromide purgation. Soluble crude antigen (EgSCA) was prepared through freeze-thaw cycles, sonication, and filtration, while recombinant fibronectin protein (rEgFN162) was obtained via gene cloning, expression, and purification in E. coli. The antigenic properties of EgSCA and rEgFN162 were analyzed by SDS-PAGE and Western blot. ELISA assays were performed to assess IgG and IgM responses in experimentally infected and treated dogs. Based on IgG ELISA results, EgSCA showed a sensitivity of 96.66 % and specificity of 66.66 %, while rEgFN162 demonstrated a sensitivity of 76.66 % and specificity of 46.66 %. In Western blot analysis, EgSCA achieved a sensitivity of 90 % and specificity of 83.33 %, whereas rEgFN162 showed 66.66 % sensitivity and 73.33 % specificity. The recombinant antigen showed a higher ability to differentiate E. granulosus infections from other helminth infections. The findings suggest that rEgFN162 is a promising candidate for the serodiagnosis of E. granulosus in dogs, with potential applications in epidemiological studies and post-treatment follow-up. Further validation with larger sample sizes is needed to confirm its diagnostic accuracy in natural infections.
dc.identifier.citationCelik, F., Selcuk, M. A., Uslug, M., & Simsek, S. (2025). Serological Diagnosis and Post-Treatment Monitoring of Echinococcus granulosus in Experimentally Infected Dogs Using Crude and Recombinant Fibronectin Antigens. Veterinary Immunology and Immunopathology, 110962.
dc.identifier.doi10.1016/j.vetimm.2025.110962
dc.identifier.issn0165-2427
dc.identifier.scopusqualityQ3
dc.identifier.urihttps://doi.org/10.1016/j.vetimm.2025.110962
dc.identifier.urihttps://hdl.handle.net/20.500.12604/8708
dc.identifier.volume285
dc.identifier.wosqualityQ2
dc.indekslendigikaynakPubMed
dc.institutionauthorSelcuk, Muhammed Ahmed
dc.institutionauthoridhttps://orcid.org/0000-0003-1769-4558
dc.language.isoen
dc.publisherElsevier BV
dc.relation.ispartofVeterinary Immunology and Immunopathology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectCrude antigen
dc.subjectDog
dc.subjectELISA
dc.subjectEchinococcus granulosus
dc.subjectFibronectin
dc.subjectSerodiagnosis
dc.subjectWestern blot.
dc.titleSerological diagnosis and post-treatment monitoring of Echinococcus granulosus in experimentally infected dogs using crude and recombinant fibronectin antigens
dc.typejournal-article
oaire.citation.volume285

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
Muhammed Ahmed-Selcuk-2025.pdf
Boyut:
1.4 MB
Biçim:
Adobe Portable Document Format
Lisans paketi
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
license.txt
Boyut:
1.17 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: